Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of diabetes comprising hyperglycemia, increased production of ketone bodies, and metabolic acidosis that is largely preventable. But instead of relying on urine testing, which has poor specificity, could there be a more reliable and effective way to monitor ketone levels? Real-time continuous ketone monitoring (CKM) is currently in development in the United States; this would integrate with continuous glucose monitoring (CGM) to help people with diabetes detect and prevent DKA. Join the Sugar Queens this month to hear more about how this new technology could decrease the risk of hospitalization for DKA and ask your questions to our expert faculty!

- - - - -
Moderator: Eden M. Miller, DO, D-ABOM, D-ACD

Faculty: Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP

Faculty: Davida F. Kruger, MSN, APN-BC, BC-ADM

- - - - -
Earn free 0.50 AMA PRA Category 1 Credit™. Access for credit will be shared at the end of this live event.

Click the link to view the Accreditation and Disclosure details before participating: Medscape.org/viewarticle/1001991

Supported by an independent educational grant from Abbott Diabetes Care.

свернуть